Showing 1511-1520 of 2050 results for "".
- Study: Specialized Smart Soft Contact Lenses Can Address Global Issue of Glaucoma Diagnosis, Managementhttps://modernod.com/news/study-specialized-smart-soft-contact-lenses-can-address-global-issue-of-glaucoma-diagnosis-management/2481144/The vision of
- Bausch Health Continuing Process Toward Separating Bausch + Lombhttps://modernod.com/news/bausch-health-continuing-process-toward-separating-bausch-lomb/2481048/Bausch Health Companies announced it is moving toward separating Bausch + Lomb after transferring common shares in an amount equal to approximately 38.6% of the issued and outstanding shares of Bausch + Lomb to an existing wholly-owned unrestricted subsidiary of the company.
- SAV-IOL Continues Progress on Electronic IOL Projecthttps://modernod.com/news/sav-iol-continues-progress-on-electronic-iol-project/2480946/SAV-IOL (Swiss Advanced Vision) provided an update on its progress toward making the first active, electronic IOL through their R-TASC Project. SAV-IOL first launched the R-TASC Project idea in 2018. "Current IOLs on the market suffer
- CORE Study Shows Importance of Rub and Rinse Regimen for Coronavirus Removal from Contact Lens Materialshttps://modernod.com/news/core-study-shows-importance-of-rub-and-rinse-regimen-for-coronavirus-removal-from-contact-lens-materials/2480905/A new study conducted by the
- Submissions Now Being Accepted for Innovation Stage Speakers and Content for Vision Expo West 2022https://modernod.com/news/submissions-now-being-accepted-for-innovation-stage-speakers-and-content-for-vision-expo-west-2022/2480883/The Vision Council and RX, co-organizers of Vision Expo, announced that submissions are being accepted for Innovation Stage speakers, presentations and panels for
- SightGlass Vision Presents 24-Month Data Demonstrating Myopia Control Efficacy for Vision Spectacle Lenseshttps://modernod.com/news/sightglass-vision-presents-24-month-data-demonstrating-myopia-control-efficacy-for-vision-spectacle-lenses/2480823/Spectacles that use SightGlass Vision Diffusion Optics Technology have demonstrated efficacy in slowing the progression of myopia in children,[1] based on 24-month interim data from its pivotal c
- Alimera Exhibits Continued Growth and Expansion With New Branding and Office Relocationhttps://modernod.com/news/alimera-exhibits-continued-growth-and-expansion-with-new-branding-and-office-relocation/2480750/Alimera Sciences announced that the company has launched new corporate branding and moved its global headquarters to a new, state-of-the-art facility. Alimera refreshed its corporate brand for the first time in the company’s two-decade history to better represent its current
- Alcon to Launch Dailies Total1 Contact Lenses in the U.S. for Patients with Astigmatismhttps://modernod.com/news/alcon-to-launch-dailies-total1-contact-lenses-in-the-us-for-patients-with-astigmatism/2480565/
- GenSight Biologics Announces Publication of Non-Human Primate Study Reporting Presence of Lumevoq Vector DNA in Contralateral Eyes After Unilateral Injectionhttps://modernod.com/news/gensight-biologics-announces-publication-of-non-human-primate-study-reporting-presence-of-lumevoq-vector-dna-in-contralateral-eyes-after-unilateral-injection/2480491/GenSight Biologics announced that the journal "Molecular Therapy – Methods and Clinical Development" has published the results of a mechanistic study demonstrating the transfer of Lumevoq vector DNA from the injected eyes to the non-injected eyes of non-human prim
- Ophthalmic Sciences Unveils AI Contactless Device for Measuring IOPhttps://modernod.com/news/ophthalmic-sciences-unveils-ai-contactless-device-for-measuring-iop/2480487/